Nguyên-Pascal, M L <br/><br/>
Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.  [electronic resource] 

 -  Climacteric : the journal of the International Menopause Society  Jun 2005 
 - 136-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1369-7137 
<br/><br/><label>Standard No.: </label>10.1080/13697130500103433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkaline Phosphatase--analysis<br/>Biomarkers<br/>Bone Density<br/>Bone Remodeling--drug effects<br/>Bone and Bones--drug effects<br/>Collagen--urine<br/>Collagen Type I<br/>Double-Blind Method<br/>Estradiol--pharmacology<br/>Estrogen Replacement Therapy--methods<br/>Female<br/>Humans<br/>Megestrol--pharmacology<br/>Menopause--drug effects<br/>Middle Aged<br/>Norpregnadienes--pharmacology<br/>Osteocalcin--analysis<br/>Peptides--urine<br/>Progesterone Congeners--pharmacology<br/>Quality of Life<br/>Surveys and Questionnaires<br/>Treatment Outcome